ECSP961660A - COMBINED THERAPY FOR HIV INFECTION - Google Patents
COMBINED THERAPY FOR HIV INFECTIONInfo
- Publication number
- ECSP961660A ECSP961660A ECSP961660A ECSP961660A EC SP961660 A ECSP961660 A EC SP961660A EC SP961660 A ECSP961660 A EC SP961660A EC SP961660 A ECSP961660 A EC SP961660A
- Authority
- EC
- Ecuador
- Prior art keywords
- hiv infection
- hiv
- combined therapy
- inhibition
- compound
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title abstract 3
- 208000037357 HIV infectious disease Diseases 0.000 title abstract 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title abstract 3
- 238000002648 combination therapy Methods 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010010369 HIV Protease Proteins 0.000 abstract 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 229940122440 HIV protease inhibitor Drugs 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000004030 hiv protease inhibitor Substances 0.000 abstract 1
- -1 immunomodular Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940042443 other antivirals in atc Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El invento se refiere a la combinación de un inhibidor de la proteasa de VIH, compuesto J, 3TC y; opcionalmente, AZT, ddC es útil en la inhibición de la proteasa de VIH, la inhibición de transcriptasa reversa de VIH, la prevención o tratamiento de la infección por VIH y el tratamiento del SIDA, ya sea como compiuetso, sales farmacéuticamente aceptables, ingredientes de la composición farmacéutica aceptables, o en combinación o no con otros antivirales, inmuno modulares, antibióticos o vacunas. También se describe los métodos para tratar el sida y los métodos para la prevención o tratamiento de la infección por VIH.The invention relates to the combination of an HIV protease inhibitor, compound J, 3TC and; optionally AZT, ddC is useful in the inhibition of HIV protease, the inhibition of HIV reverse transcriptase, the prevention or treatment of HIV infection, and the treatment of AIDS, either as a compound, pharmaceutically acceptable salts, ingredients of the acceptable pharmaceutical composition, or in combination or not with other antivirals, immunomodular, antibiotics or vaccines. Also described are methods of treating AIDS and methods for preventing or treating HIV infection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961660 ECSP961660A (en) | 1996-01-31 | 1996-01-31 | COMBINED THERAPY FOR HIV INFECTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961660 ECSP961660A (en) | 1996-01-31 | 1996-01-31 | COMBINED THERAPY FOR HIV INFECTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961660A true ECSP961660A (en) | 1997-07-28 |
Family
ID=42042394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961660 ECSP961660A (en) | 1996-01-31 | 1996-01-31 | COMBINED THERAPY FOR HIV INFECTION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961660A (en) |
-
1996
- 1996-01-31 EC ECSP961660 patent/ECSP961660A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9204720A (en) | QUINAZOLINE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS. | |
| MX9304775A (en) | BENZOXAZINONES AS REVERSE HIV TRANSCRIPTASE INHIBITORS. | |
| ES2125251T3 (en) | HIV PROTEASE INHIBITORS. | |
| ES2186787T3 (en) | USE OF RITONAVIR (ABT-538) TO IMPROVE THE PHARMACOCINETICS OF MEDICINES METABOLIZED BY THE CYCROCHROME P450 IN A METHOD OF TREATMENT OF AIDS. | |
| ES2178037T3 (en) | CYCLOSPORINE DERIVATIVES, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| ES2178036T3 (en) | CYCLOSPORINE DERIVATIVES, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN YOU. | |
| DE69531944D1 (en) | NEW HIV PROTEASE INHIBITORS | |
| ES2157252T3 (en) | APPLICATION OF RILUZOL IN THE TREATMENT OF NEURO-AIDS. | |
| ES2174921T3 (en) | HIV PROTEASE INHIBITORS. | |
| MX9705916A (en) | Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc. | |
| MX9302681A (en) | NEW QUINAZOLINS AS REVERSE HIV TRANSCRIPTASE INHIBITORS. | |
| CO4130200A1 (en) | HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT | |
| MX9700036A (en) | Combination therapy for hiv infection. | |
| AR013758A1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF AIDS. | |
| ECSP961660A (en) | COMBINED THERAPY FOR HIV INFECTION | |
| MX9701121A (en) | Hiv protease inhibitor combination. | |
| PT1411956E (en) | UTILIZATION OF OVER-SULPHATED POLYNOSTAKERS AS HIV INHIBITORS | |
| ECSP982741A (en) | COMBINED THERAPY FOR THE TREATMENT OF AIDS | |
| ECSP003786A (en) | RANGE-HYDROXIL-2 (FLUOROALQUILOAMINOCARBONIL) -1-PIPERACINAPENTANAMIDAS AND USES OF THEM | |
| FI970565A0 (en) | HIV proteasinhibitorkombination | |
| DOP2001000263A (en) | AZA AND POLIAZA-NAFTALENIL CARBOXAMIDES USEFUL AS INHIBITORS OF HIV INTEGRESS | |
| KR970703770A (en) | Combination therapy for HIV infection |